These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 30530966

  • 1. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
    Zhang H, Wang J, Wang Z, Ruan C, Wang L, Guo H.
    Cancer Biomark; 2019; 24(1):43-49. PubMed ID: 30530966
    [Abstract] [Full Text] [Related]

  • 2. Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma.
    Chen J, Yang L, Wang X.
    Cancer Biomark; 2017 Dec 06; 20(4):521-526. PubMed ID: 28946553
    [Abstract] [Full Text] [Related]

  • 3. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    Wang ZQ, Zhang MY, Deng ML, Weng NQ, Wang HY, Wu SX.
    PLoS One; 2017 Dec 06; 12(9):e0184969. PubMed ID: 28931080
    [Abstract] [Full Text] [Related]

  • 4. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X, Lan F, Hu M, Pan Q, Wang Q, Wang J.
    J Neurosurg; 2016 Jan 06; 124(1):122-8. PubMed ID: 26230475
    [Abstract] [Full Text] [Related]

  • 5. Circulating microRNA-137 is a potential biomarker for human glioblastoma.
    Li HY, Li YM, Li Y, Shi XW, Chen H.
    Eur Rev Med Pharmacol Sci; 2016 Sep 06; 20(17):3599-604. PubMed ID: 27649660
    [Abstract] [Full Text] [Related]

  • 6. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G, Terrenato I, Spagnuolo M, Carosi M, Cognetti G, Cicchillitti L, Sperati F, Villani V, Carapella C, Piaggio G, Pelosi A, Rizzo MG.
    J Exp Clin Cancer Res; 2016 Jul 30; 35(1):124. PubMed ID: 27476114
    [Abstract] [Full Text] [Related]

  • 7. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
    Lan F, Qing Q, Pan Q, Hu M, Yu H, Yue X.
    Cell Oncol (Dordr); 2018 Feb 30; 41(1):25-33. PubMed ID: 29076027
    [Abstract] [Full Text] [Related]

  • 8. Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme.
    Tan SK, Pastori C, Penas C, Komotar RJ, Ivan ME, Wahlestedt C, Ayad NG.
    Mol Cancer; 2018 Mar 20; 17(1):74. PubMed ID: 29558959
    [Abstract] [Full Text] [Related]

  • 9. Clinical impact of circulating oncogenic MiRNA-221 and MiRNA-222 in glioblastoma multiform.
    Swellam M, Ezz El Arab L, Al-Posttany AS, B Said S.
    J Neurooncol; 2019 Sep 20; 144(3):545-551. PubMed ID: 31422498
    [Abstract] [Full Text] [Related]

  • 10. MiR-330-3p and miR-485-5p as biomarkers for glioblastoma: An integrated bioinformatics and experimental study.
    Rahmati Y, Alivand M, Mollanoori H.
    Comput Biol Chem; 2021 Jun 20; 92():107458. PubMed ID: 33761401
    [Abstract] [Full Text] [Related]

  • 11. Emerging role of miRNAs as liquid biopsy markers for prediction of glioblastoma multiforme prognosis.
    Swellam M, Bakr NM, El Magdoub HM, Hamza MS, Ezz El Arab LR.
    J Mol Neurosci; 2021 Apr 20; 71(4):836-844. PubMed ID: 32989634
    [Abstract] [Full Text] [Related]

  • 12. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
    Tabibkhooei A, Izadpanahi M, Arab A, Zare-Mirzaei A, Minaeian S, Rostami A, Mohsenian A.
    Clin Neurol Neurosurg; 2020 Mar 20; 190():105652. PubMed ID: 31896490
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients.
    Kefayat A, Amouheidari A, Ghahremani F, Alirezaei Z.
    Cancer Med; 2021 Aug 20; 10(15):5154-5162. PubMed ID: 34250760
    [Abstract] [Full Text] [Related]

  • 14. Serum expression level of miR-504 can differentiate between glioblastoma multiforme and solitary brain metastasis of non-small cell lung carcinoma.
    Jin Z, Jin RH, Ma C, Li HS, Xu HY.
    J BUON; 2017 Aug 20; 22(2):474-480. PubMed ID: 28534372
    [Abstract] [Full Text] [Related]

  • 15. Analysis of Glioblastoma Patients' Plasma Revealed the Presence of MicroRNAs with a Prognostic Impact on Survival and Those of Viral Origin.
    Herman A, Gruden K, Blejec A, Podpečan V, Motaln H, Rožman P, Hren M, Zupančič K, Veber M, Verbovšek U, Lah Turnšek T, Porčnik A, Koršič M, Knežević M, Jeras M.
    PLoS One; 2015 Aug 20; 10(5):e0125791. PubMed ID: 25950799
    [Abstract] [Full Text] [Related]

  • 16. Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer.
    Sun Y, Yang B, Lin M, Yu H, Chen H, Zhang Z.
    Cancer Biomark; 2019 Aug 20; 24(3):299-305. PubMed ID: 30829615
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic and prognostic significance of serum miR-145-5p expression in glioblastoma.
    Zhang Y, Ta WW, Sun PF, Meng YF, Zhao CZ.
    Int J Clin Exp Pathol; 2019 Aug 20; 12(7):2536-2543. PubMed ID: 31934080
    [Abstract] [Full Text] [Related]

  • 18. Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma.
    Wang Q, Li P, Li A, Jiang W, Wang H, Wang J, Xie K.
    J Exp Clin Cancer Res; 2012 Nov 22; 31(1):97. PubMed ID: 23174013
    [Abstract] [Full Text] [Related]

  • 19. Serum microRNA profiling in patients with glioblastoma: a survival analysis.
    Zhao H, Shen J, Hodges TR, Song R, Fuller GN, Heimberger AB.
    Mol Cancer; 2017 Mar 11; 16(1):59. PubMed ID: 28284220
    [Abstract] [Full Text] [Related]

  • 20. MiR-106a is an independent prognostic marker in patients with glioblastoma.
    Zhao S, Yang G, Mu Y, Han D, Shi C, Chen X, Deng Y, Zhang D, Wang L, Liu Y, Hou X, Wang C, Wu J, Liu H, Wang L, Zhang G, Qi J, Fang X, Shi C, Ai J.
    Neuro Oncol; 2013 Jun 11; 15(6):707-17. PubMed ID: 23416698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.